Table 5.
Potential effects of Citrus aurantifolia swings in treatment of CHF.
| Study | Therapeutic component | Dose/active constitute/extract | Type of study | Major findings/mechanism |
|---|---|---|---|---|
| Souza et al[128] | Inotropic | aqueous extract of C aurantifolia | In vitro rat aorta | Negative inotropic and chronotropic effects on the heart contractile activity |
| Akhtar[129] | Antihypertensive | methanol extract of C aurantifolia 0.75mg orally | In vivo rats | Significantly reduced systolic blood pressure, mean blood pressure, diastolic blood pressure, heart rate and body weight in both normotensive and hypertensive experimental models |
| Souza et al[128] | Antihypertensive | aqueous extract of C aurantifolia | In vivo rabbit | Dose-dependent and significant decrease in blood pressure of adrenalin-evoked hypertension |
| Hashemipour et al[131] | Antihypertensive | C aurantifolia peels | Triple-masked randomized controlled trial in adolescents with excess weight | SBP was significantly decreased in intervention group in a before-after analysis |
| Siti et al[132] | Antihypertensive | Citrus leaf extract | In vivo palm oil induced-hypertension Sprague Dawley rats | Reduce blood pressure, thromboxane and angiotensin-1 converting enzyme |
| Souza et al[128] | Vasodilator | aqueous extract of C aurantifolia | In vivo rabbit | Dose dependent relaxation of contractions produced by adrenalin |
CHF = chronic heart failure, SBP = systolic blood pressure.